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ABSTRACT  
Objective: The purpose of this research is to evaluate the antifungal activity of synthesized conjugates of thiophene with 1, 3, 4-oxadiazoles and 1, 
3, 4-thiadiazoles using in vitro methods. 
Methods: The series of (IVa-e) and (Va-e) compounds were synthesized from thiosemicarbazide (IIIa-e) series by treating with iodine-sodium 
hydroxide mixture and by phosphoric acid cyclization respectively. Thiosemicarbazides (IIIa-e) were prepared by the reaction of 2–amino-4, 5, 6, 7-
tetrahydro-benzo[b]thiophene-3-carbohydrazide (II) with substituted isothiocyanates. Carbohydrazide (II) was synthesized by the reaction of 
hydrazine hydrate with ethyl 2–amino-4, 5, 6, 7-tetrahydrobenzeno[b]thiophene-3-carboxylate (I), which was prepared by one pot synthesis 
method. Finally, the synthesized compound series was characterized by physicochemical and spectral data (IR, NMR and Mass) and evaluated for in 
vitro antifungal activity against Candida albicans and Aspergillus niger using disc diffusion method. The percentage inhibition was calculated with 
reference to the standard drug. 
Results: The structures of the synthesized conjugates of thiophene with 1, 3, 4-oxadiazoles and 1, 3, 4–thiadiazoles were confirmed by IR, NMR, and 
Mass spectroscopic techniques. The results of bioassay were indicated that some synthesized compounds IVd, IVe, Vd, and Ve exhibited moderate 
antifungal activities against Candida albicans and Aspergillus niger; whereas compounds IVb, IVc, Vb, and Vc showed prominent antifungal activities 
when compared to standard drug, Fluconazole.  
Conclusion: Present study demonstrates the synthesis of conjugates of thiophene with 1, 3, 4-oxadiazoles and 1, 3, 4–thiadiazoles. These compounds 
were evaluated for in vitro antifungal activity against Candida albicans and Aspergillus niger using disc diffusion method. The compounds IVd, IVe, Vd, 
and Ve exhibited moderate antifungal activities, whereas compounds IVb, IVc, Vb, and Vc showed prominent antifungal activities.  
Keywords: Oxadiazole, Thaidiazole, Thiosemicarbazide; Antifungal activity.  
 
INTRODUCTION 
In the medicinal chemistry, 1, 3, 4-oxadiazole and 1, 3, 4–
thiadiazoles are most widely used heterocyclic moiety for the 
development of new therapeutic agents [1, 2]. The designing of 
antifungal drugs is more challenging than that of antibacterial agents 
due to higher complexity and closeness to mammalian cell [3]. 
Therefore, designing of such agents is challenging which are toxic to 
fungi, but non-toxic to humans [4]. The oxadiazole and thiadiazoles 
are cyclic analogues of thiosemicarbazide having significant 
antifungal activities [5]. The compounds containing these 
heterocyclic nuclei possess various biological activities including 
anti-inflammatory [6-8], anticonvulsant [9, 10], anthelmintic [11], 
diuretic [12], anti-tubercular [13],anticancer [14], and antimicrobial 
activities [15-17]. Earlier studies revealed an affinity of 1, 3, 4-
oxadiazoles and 1, 3, 4–thiadiazoles on fungal targets [16, 17]. In 
addition, thiophenes have been reported as the biologically active 
agent for fungal targets [18]. 
Keeping in view the above, an attempt has been made in the present 
study to synthesize some new conjugates of thiophene with 
oxadiazoles and thiadiazoles and screen them for antifungal activity 
to find some new compounds having potential activity. Therefore, 
these derivatives have been synthesized, characterized by IR, Mass 
and NMR spectroscopic techniques and screened for their in vitro 
antifungal activity against Candida albicans and Aspergillus niger 
using the disc diffusion method. Such findings can help in developing 
highly potent antifungal agents with least side effects.  
MATERIALS AND METHODS  
Chemistry 
The title compounds (IVa-e and Va-e) were synthesized as per 
reaction scheme and their structures were confirmed by IR, NMR, and 
Mass spectroscopy. The starting material and reagents were procured 
from commercial chemical suppliers and of analytical grade. 
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The purity of the compounds was checked by TLC on silica gel G 
sheets using chloroform: methanol, 7:3 solvent system and UV lamp 
used as visualizing agent. IR spectra were recorded using KBr pellets 
on a Thermo Nicolet Nexus 670 spectrophotometer with resolution 
4 cm-1. 1H NMR spectra were recorded on Amx 400 NMR 
spectrometer at 400 MHZ spectrophotometer using DMSO as solvent 
and TMS as internal standard. The values of chemical shift (δ) are 
given in ppm. Mass spectra were done by LCMS–2010 techniques 
Synthesis of ethyl-2-amino-4, 5, 6, 7-tetrahydro-benzo(b) 
thiophene-3-carboxylate (I) 
An equimolar mixture of cyclohexanone (0.1 mol), sulphur (0.1 mol), 
ethyl cyanoacetate (0.1 mol) and diethyl amine (0.1 mol) in dry 
ethanol (20 ml) were taken in a 500 ml round bottomed flask and 
stirred for 1.5 h. The mixture was then poured into ice-cold water, 
with constant stirring and set aside for 3 h at room temperature [18, 
19]. The separated solid was filtered, dried and recrystallized from 
ethanol. Yield: 82.75 %, MP-102 °C. 
Synthesis of ethyl, 2-amino-4, 5, 6, 7-tetrahydro-
benzo(b)thiophene-3-carbohydrazide (II) 
Compound I (0.1 mol) was dissolved in 20 ml ethanol and stirred 
magnetically for 0.5 h. Then hydrazine hydrate (99 %) was added to 
it and this mixture was heated under reflux on a water bath for 4 h. 
The reaction mixture, then poured onto ice which led to separation 
of colorless crystalline solid. The product was recrystallized from 
ethanol. Yield: 75.83 %, MP-105 °C. 
Synthesis of 2-[(2-amino-4, 5, 6, 7-tetrahydro-1-benzothiophen-
3yl) carbonyl]-N-substituted hydrazine carbothioamide (IIIa-e) 
An appropriate isothiocyanate (0.1 mol) was added into a 
suspension of compound II (0.1 mol) in dry benzene. The mixture 
was heated under reflux for 3 h on the steam bath and then poured 
onto ice [20]. The corresponding thiosemicarbazide separated was 
collected, dried and recrystallized from ethanol. 
Synthesis of 5-(2-amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-
yl)-N-substituted-1, 3, 4-oxadiazole-2-amines (IVa-e) 
A cold solution of sodium hydroxide (4 %) was added to an equimolar 
mixture of corresponding compound IIIa-e (0.1 mol) in ethanol. To 
this, a solution of iodine in potassium iodide (aqueous, 5 %) was 
added in portions with vigorous shaking until the color of iodine 
persisted at room temperature. The reaction mixture was heated 
under reflux for 1 h and concentrated under reduced pressure. It was 
poured onto crushed ice and recrystallized from petroleum ether.  
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-ethyl-1, 
3, 4-oxadiazole-2-amine (IVa) 
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H aliphatic), 1366 (C=N), 1274 (N-N), 781 (C-S-C). 1H 
NMR (DMSO-d6) δ: 4.2 (s, 3H of 3. NH), 7.7 (s, 2H of NH2), 4.2 (s, 3H 
of CH3), 1.4-2.7(m, 8H of CH2 aliphatic), 4.2-4.3 (t, 3H of CH3), 1.2-1.3 
(q, 2H of CH2). MS m/z (%): M+1 = 265. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-phenyl-
1, 3, 4-oxadiazole-2-amine (IVb): [21]  
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H aliphatic), 1366 (C=N), 1274 (N-N), 781 (C-S-C). 1H 
NMR (DMSO-d6): δ 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 5.9-6.2 (m, 
5H of Ar-H), 1.4-2.7 (m, 8H of CH2 aliphatic). MS m/z (%): M+1 = 312. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-(4-
methoxyphenyl)-1, 3, 4-oxadiazol-2-amine (IVc) 
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H aliphatic), 1366 (C=N), 1274 (N-N), 781(C-S-C). 1H 
NMR (DMSO-d6) δ: 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 5.9-6.2 (m, 
4H of Ar-H), 4.2 (s, 3H of CH3), 1.4-2.7 (m, 8H of CH2 Aliphatic). MS 
m/z (%): M+1 = 343. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-(4-
methyl phenyl)-1, 3, 4-oxadiazole-2-amine (IVd) 
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H aliphatic), 1366 (C=N), 1274 (N-N), 781 (C-S-C). 1H 
NMR (DMSO-d6): δ 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 5.9-6.2 (m, 
4H of Ar-H), 4.4 (s, 3H of CH3), 1.4-2.7 (m, 8H of CH2 Aliphatic). MS 
m/z (%): M+1 = 327. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-(4-
chloro phenyl)-1, 3, 4-oxadiazole-2-amine (IVe) 
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H aliphatic), 1366 (C=N), 1274 (N-N), 781 (C-S-C). 1H 
NMR (DMSO-d6) δ: 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 6.2-7.1 (m, 
4H of Ar-H), 1.4-2.7 (m, 8H of CH2 Aliphatic). MS m/z (%): M+1 = 
347. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-
substituted-1, 3, 4-Thiadiazole-2-amine (Va-e)  
Phosphoric acid, (10 ml, 0.1 mol) was added slowly to the 
corresponding compound IIIa-e (0.1 mol). The mixture was heated 
at 110-130 °C for 0.5 h and then poured onto crushed ice with 
continuous stirring. The product was obtained, dried and 
recrystallized from petroleum ether.  
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-ethyl-1, 
3, 4-thiadiazole-2-amine (Va)  
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H) aliphatic, 1366 (C=N), 1274 (N-N), 781 (C-S-C). 1H 
NMR (DMSO-d6) δ: 7.7 (s, 2H of NH2), 4.2 (s, 3H of 3. NH), 4.2 (s, 3H 
of CH3), 1.4-2.7 (m, 8H of CH2 aliphatic), 4.2-4.3  
(t, 3H of CH3), 1.2-1.3 (q, 2H of CH2). MS m/z (%): M+1 = 281. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-phenyl-
1, 3, 4-thiadiazole-2-amine (Vb): [22] 
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H) aliphatic, 1366 (C=N), 1274 (N-N), 781 (C-S-C).1H 
NMR (DMSO-d6) δ: 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 5.9-6.2 (m, 
5H of Ar-H),1.4-2.7 (m, 8H of CH2 Aliphatic). MS m/z (%): M+1 = 
329. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-(4-
methoxyphenyl)-1, 3, 4-thiadiazole-2-amine (Vc)  
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H) aliphatic, 1366 (C=N), 1274 (N-N), 781(C-S-C). 1H 
NMR (DMSO-d6) δ: 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 5.9-6.2 (m, 
4H of Ar-H), 4.2 (s, 3H of CH3), 1.4-2.7 (m, 8H of CH2 aliphatic). MS 
m/z (%): M+1 = 359. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-(4-
methyl phenyl)-1, 3, 4-thiadiazole-2-amine (Vd)  
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H) aliphatic, 1366 (C=N), 1274 (N-N), 781(C-S-C). 1H 
NMR (DMSO-d6) δ: 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 5.9-6.2(m, 
4H of Ar-H), 4.4 (s, 3H of CH3), 1.4-2.7 (m, 8H of CH2 aliphatic). MS 
m/z (%): M+1 = 343. 
5-[(2-Amino-4, 5, 6, 7-tetrahydro-1-benzothien-3-yl)-N-(4-
chloro phenyl)-1, 3, 4-thiadiazole-2-amine (Ve)  
IR (KBr, νmax, cm-1): 3384 (NH str.), 3299 (NH2), 2938 (CH str.), 3405 
(NH), 2840 (C-H) aliphatic, 1366 (C=N), 1274 (N-N), 781 (C-S-C). 1H 
NMR (DMSO-d6) δ: 7.7 (s, 1H of NH2), 3.8 (s, 3H of 3. NH), 6.2-7.1 (m, 
4H of Ar-H), 1.4-2.7 (m, 8H of CH2 aliphatic). MS m/z (%): M+1 = 364. 
Antifungal activity 
All synthesized compounds (IV a-e and Va-e) were evaluated for 
their in vitro antifungal activities against Candida albicans 
(MTCC1785) and Aspergillus niger (MTCC2479) with DMF as a 
solvent control [23, 24]. The results of preliminary bioassays were 
compared with experimental data of antifungal drug, Fluconazole. 
Inoculation of the fungal strains were done under the aseptic 
conditions in sterilized petri-plates containing Sabouraud’s dextrose 
agar. The sterilized discs (6 mm) were placed on the fungal mycelia 
after dipping into a desired solution of test compounds and standard 
drug (50μg/ml and 100 μg/ml). Finally, Petri-plates were incubated 
at 25±1 oC for 72 h. After incubation, a zone of inhibition was 
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measured on mm scale and % inhibition was calculated with 
reference to the standard drug. Data were statistically analyzed 
(mean±SD) as shown in table 2. 
RESULTS AND DISCUSSION 
The title compounds were synthesized as per reaction scheme, i.e. 
the series of (IVa-e) and (Va-e) compounds were synthesized by 
thiosemicarbazide (IIIa-e) series by treating with iodine-sodium 
hydroxide mixture and by cyclization using phosphoric acid 
respectively [24, 25].  
The structures were elucidated by physicochemical (table 1) and 
spectral data (IR, NMR and Mass spectra) for the synthesized 
compounds which are reported in experimental protocols. 
The antifungal screening of the compounds IVa-e and Va-e, was done 
by disc diffusion method against Candida albicans and Aspergillus 
niger which was compared with Fluconazole described in literature 
[26, 27].  
It has been observed that most of compounds showed inhibition 
(between 33.8 to 66.1%) against C. albicans and A. niger (table 2). 
 
Table 1: Physical data of substituted 1, 3, 4-Oxadiazoles and 1, 3, 4-Thiadiazoles 
S. No. Compound code R Molecular formula MP (oC) Rf Value Yield (%) 
1 IVa Ethyl C12H16N4SO 108 0.82 39 
2 IVb Phenyl C16H16N4SO 105 0.80 37 
3 IVc 4-Methoxy Phenyl C17H18N4SO2 107 0.75 36 
4 IVd 4-Methyl Phenyl C17H18N4SO 106 0.78 34 
5 IVe 4-Chloro Phenyl C16H15N4SOCl 109 0.71 35 
6 Va Ethyl C12H16N4S2 98 0.90 34 
7 Vb Phenyl C16H16N4S2 106 0.88 29 
8 Vc 4-Methoxy Phenyl C17H18N4S2O 105 0.74 26 
9 Vd 4-Methyl Phenyl C17H18N4S2 102 0.76 24 
10 Ve 4-Chloro Phenyl C16H15N4S2Cl 101 0.86 32 
 
Table 2: Data for Antifungal activity of substituted 1, 3, 4-Oxadiazoles and 1, 3, 4-Thiadiazoles 
Compound 
Code 
Zone of Inhibition (in mm) (mean±SD)a and % Inhibition with reference to Standard drugb 
C. albicans A. niger 
50µg/ml 100 µg/ml 50 µg/ml 100 µg/ml 
























































































 amean±SD, n=3 (zone of inhibition observed in triplicates), bThe percentage zone of inhibition was calculated against C. albicans and A. niger with 
reference to standard, solvent control-DMF, cStandard drug: Fluconazole (50µg/ml & 100 µg/ml concentrations) 
 
From the results listed in table 2, it can be observed that the 
compounds IVd, IVe, Vd, and Ve at 50 μg/ml concentration, showed 
53.9%, 59.9%, 55.4% and 66.1% inhibition, respectively against 
Candida albicans; whereas compounds IVb, IVc, Vb, and Vc showed 
38.4%, 44.6%, 46.2% and 43.1% inhibition respectively. Similarly, 
compounds IVd, IVe, Vd, and Ve at 100 μg/ml concentration, 
exhibited 60.8%, 59.5%, 55.4% and 59.5% inhibition, respectively 
against same fungus; whereas compounds IVb, IVc, Vb, and Vc 
exhibited 43.3%, 45.9%, 51.4% and 41.9% inhibition respectively. 
The compounds IVd, IVe, Vd, and Ve at 50 μg/ml concentration, 
showed 56.3%, 59.4%, 57.8% and 60.9% inhibition, respectively 
against Aspergillus niger; whereas compounds IVb, IVc, Vb, and Vc 
showed 40.6%, 39.1%, 43.7% and 40.6% inhibition respectively. 
Similarly, compounds IVd, IVe, Vd, and Ve at 100 μg/ml 
concentration, exhibited 55.9%, 64.7%, 64.7% and 63.2% inhibition, 
respectively against same fungus; whereas compounds IVb, IVc, Vb, 
and Vc exhibited 42.7%, 39.7%, 49.9% and 41.2% inhibition 
respectively. 
It can be concluded from these data, the compounds IVd, IVe, Vd, and 
Ve exhibited moderate antifungal activities against C. albicans as 
those of Fluconazole at 50µg/ml concentration, whereas compounds 
IVb, IVc, Vb, and Vc showed prominent antifungal activities. The 
compounds IVd, IVe, Vd, and Ve at 50 μg/ml concentration, showed 
slightly lower antifungal activities against A. niger; whereas 
compounds IVb, IVc, Vb, and Vc showed prominent activities. Since, 
the solutions of all test compounds and standard drugs were 
prepared in DMF and the zone of inhibition of DMF solvent control 
was found to be negligible and assumed to be zero mm. 
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The present study revealed that the antifungal activity of 
compounds depends on the nature of substituents and it also differs 
by the presence of the oxadiazole or thiadiazole ring. The 
synthesized compounds IVe and Ve (R=4-chlorophenyl) on amino 
linkage of 1, 3, 4-oxadiazole or 1, 3, 4-thiadiazole ring showed 
highest antifungal activity against both C. albicans and A. niger. Out 
of these, Ve showed much higher activity than that of IVe. Similarly, 
the compound Vd (R=4-methyl phenyl) and Vb (R=phenyl) exhibited 
better activities than those of IVd and IVb. All these changes 
occurred because of difference in the presence of the oxadiazole or 
thiadiazole ring. In contrast to this, the compounds IVc and Vc (R=4-
methoxy phenyl) showed slightly lower activities these of IVd and 
Vd. The activities of compounds IVa and Va (R=ethyl) were found to 
be the lowest one. Finally, the order of activity was 
Ve>IVe>Vd>IVd>IVc>Vc>Vb>IVb>Va>IVa. The activity of Vc was 
exceptionally lower than that of IVc. 
In addition,-N-N=C-linkage common to both in oxadiazole or 
thiadiazole moeity played a crucial role in determination of antifungal 
activity due to structural similarities with pharmacophoric part of the 
standard drug. It is interesting to observe that further structural 
modifications on oxadiazole and thiadiazole ring can be utilized as 
potential therapeutic agents in future.  
CONCLUSION 
The present study reported the synthesis of bioactive compounds 
containing oxadiazole and thiadiazole and characterization using IR, 
NMR, and Mass spectroscopic methods. Antifungal activity against 
Candida albicans and Aspergillus niger using the disc diffusion 
method was demonstrated. From these data, compounds IVd, IVe, 
Vd, and Ve exhibited moderate antifungal activities against C. 
albicans than those of Fluconazole at 50µg/ml concentrations, 
whereas compounds IVb, IVc, Vb, and Vc showed prominent 
antifungal activities. The compounds IVd, IVe, Vd, and Ve at 50 
μg/ml concentration, showed slightly lower antifungal activities 
against A. niger; whereas compounds IVb, IVc, Vb, and Vc showed 
prominent activities. 
The antifungal screening of these synthesized compounds was 
considered to have optimal binding with targets and explore the 
new possibilities for drug-target interactions. The research field is 
open for further optimization of these antifungal agents with respect 
to pharmacokinetic and toxicology studies. 
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